ARGX:EURONEXT BRUSSELSargenx SE Analysis

argenx SE is trading around its 20‑day and 200‑day moving averages with a neutral RSI near 50 and a MACD histogram turning slightly negative, suggesting short‑term caution. The stock is priced well above its 50‑day SMA and faces a resistance near the recent high, while support sits comfortably above the 30‑day volatility band.
Fundamentally, the company posted a 62% revenue surge year‑over‑year, delivering strong gross (58%) and operating (30%) margins, and it holds a robust cash pile with minimal debt. However, the current PE of roughly 36 versus an industry average of 28, and an astronomically high price‑to‑book ratio, flag an overvalued market stance despite a forward PE under 22. Upcoming Q1 earnings, which are expected to show a 60% revenue jump, will be a pivotal catalyst, and the recent leadership transition adds a strategic narrative to the growth outlook.